We estimate that Bristol-Myers Squibb's (NYSE: BMY) R&D expenses will grow in the low single digits to $4.81 billion in 2018. However, we expect a slight decline in R&D expenditure as a percentage of BMY's gross profit. Currently, the R&D expenses as a percentage of gross profit are a little...
We estimate that Bristol-Myers Squibb's (NYSE: BMY) R&D expenses will grow in the low single digits to $4.81 billion in 2018. However, we expect a slight decline in R&D expenditure as a percentage of BMY's gross profit. Currently, the R&D expenses as a percentage of gross profit are a little...
Share this Article
Recommended